Home Biotechnology Gene Synthesis Market Size & Trends Report | 2033

Gene Synthesis Market Size & Outlook, 2025-2033

Gene Synthesis Market Size, Share & Trends Analysis Report By Method  (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service (Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Application  (Gene and Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others), By End-User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI2274DR
Last Updated : May, 2025
Pages : 110
Author : Dhanashri Bhapakar
Format : PDF, Excel

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Gene Synthesis Market Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. U.S.
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Canada
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. U.K.
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. China
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. UAE
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. Brazil
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Gene Synthesis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. GenScript
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Brooks Automation, Inc. (GENEWIZ)
    3. Boster Biological Technology
    4. Twist Bioscience
    5. ProteoGenix
    6. Biomatik
    7. ProMab Biotechnologies, Inc.
    8. Thermo Fisher Scientific, Inc.
    9. Integrated DNA Technologies, Inc.
    10. OriGene Technologies, Inc. 
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :